Miller Mary (CIK 1841088) reported 14 SEC Form 4 insider transactions across 1 companies over the past 18 months (most recent 2026-05-20). Recent activity: Buy ACRV (49,830 shares), Sell ACRV (184 shares), Sell ACRV (558 shares), Sell ACRV (217 shares), Sell ACRV (659 shares). Source: SEC Form 4.
| Date | Company | Role | Type | Shares | Value |
|---|---|---|---|---|---|
| 2026-05-20 | Acrivon Therapeutics, Inc. (ACRV) | Chief Legal Officer | Buy | 49,830 | $0 |
| 2026-05-18 | Acrivon Therapeutics, Inc. (ACRV) | Chief Legal Officer | Sell | 184 | $353 |
| 2026-04-21 | Acrivon Therapeutics, Inc. (ACRV) | Chief Legal Officer | Sell | 558 | $993 |
| 2026-02-18 | Acrivon Therapeutics, Inc. (ACRV) | Chief Legal Officer | Sell | 217 | $354 |
| 2026-01-21 | Acrivon Therapeutics, Inc. (ACRV) | Chief Legal Officer | Sell | 659 | $1,305 |
| 2025-11-18 | Acrivon Therapeutics, Inc. (ACRV) | Chief Legal Officer | Sell | 184 | $412 |
| 2025-10-21 | Acrivon Therapeutics, Inc. (ACRV) | Chief Legal Officer | Sell | 558 | $1,010 |
| 2025-10-03 | Acrivon Therapeutics, Inc. (ACRV) | Chief Legal Officer | Sell | 284 | $514 |
| 2025-08-18 | Acrivon Therapeutics, Inc. (ACRV) | Chief Legal Officer | Sell | 184 | $256 |
| 2025-07-21 | Acrivon Therapeutics, Inc. (ACRV) | Chief Legal Officer | Sell | 558 | $737 |
| 2025-05-16 | Acrivon Therapeutics, Inc. (ACRV) | Chief Legal Officer | Sell | 184 | $210 |
| 2025-04-18 | Acrivon Therapeutics, Inc. (ACRV) | Chief Legal Officer | Sell | 558 | $1,010 |
| 2025-02-19 | Acrivon Therapeutics, Inc. (ACRV) | Chief Legal Officer | Sell | 217 | $1,176 |
| 2025-01-22 | Acrivon Therapeutics, Inc. (ACRV) | Chief Legal Officer | Sell | 659 | $3,809 |
Source: SEC Form 4 filings · as of 2026-05-20